KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Assets Average: 2011-2025

Historic Assets Average for Rigel Pharmaceuticals (RIGL) over the last 14 years, with Sep 2025 value amounting to $224.6 million.

  • Rigel Pharmaceuticals' Assets Average rose 67.75% to $224.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.6 million, marking a year-over-year increase of 67.75%. This contributed to the annual value of $140.6 million for FY2024, which is 11.81% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Assets Average stood at $224.6 million for Q3 2025, which was up 17.39% from $191.4 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Assets Average registered a high of $224.6 million during Q3 2025, and its lowest value of $116.2 million during Q3 2023.
  • Over the past 3 years, Rigel Pharmaceuticals' median Assets Average value was $128.9 million (recorded in 2023), while the average stood at $145.7 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Assets Average slumped by 37.23% in 2022 and then surged by 67.75% in 2025.
  • Rigel Pharmaceuticals' Assets Average (Quarterly) stood at $176.9 million in 2021, then decreased by 29.38% to $124.9 million in 2022, then declined by 6.94% to $116.3 million in 2023, then spiked by 30.46% to $151.7 million in 2024, then spiked by 67.75% to $224.6 million in 2025.
  • Its Assets Average was $224.6 million in Q3 2025, compared to $191.4 million in Q2 2025 and $170.0 million in Q1 2025.